Lichenoid dermatitis induced by abemaciclib in a patient with HR+/HER2- breast cancer
Cyclin-dependent kinase (CDK) 4/6 inhibitors, such as palbociclib, ribociclib, and abemaciclib, are widely used in combination with endocrine therapy for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Despite their efficacy,...
Tallennettuna:
Päätekijät: | , , , , , , , |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
PAGEPress Publications,
2024-11-01T00:00:00Z.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
Hyllypaikka: |
A1234.567 |
---|---|
Nide 1 | Saatavissa |